Hyperion DeFi, Inc. (HYPD) vs XBiotech Inc. (XBIT)
Hyperion DeFi, Inc. and XBiotech Inc. are both Biotechnology companies. Hyperion DeFi, Inc. and XBiotech Inc. are of similar size ($65.9M and $64.8M). Hyperion DeFi, Inc. grew revenue faster over the last twelve months: 1,990.6% against −78.2%. XBiotech Inc. has the higher net margin (0.00% vs −1,224.5%) and the lower return on invested capital (−159.2% vs 2.73%). Across the 18 metrics below, XBiotech Inc. leads on 10 and Hyperion DeFi, Inc. on 8.
Valuation
Profitability
| Metric | HYPD | XBIT | Biotechnology median |
|---|---|---|---|
| Gross margin | 78.35% | 0.00% | 65.16% |
| Operating margin | 314.32% | 0.00% | 0.00% |
| Net margin | (1,224.53%) | 0.00% | 0.00% |
| Free cash flow margin | (5,509.35%) | 0.00% | 0.00% |
| Return on equity | (24.63%) | (29.94%) | (57.72%) |
| Return on assets | (20.32%) | (28.90%) | (49.22%) |
| Return on invested capital | 2.73% | (159.18%) | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack